MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $247,000 | -99.1% | 3,000 | -98.4% | 0.00% | -98.9% |
| Q4 2021 | $26,910,000 | +2.2% | 183,446 | +23.3% | 0.28% | -11.9% |
| Q3 2021 | $26,329,000 | +158.4% | 148,827 | +135.9% | 0.31% | +131.1% |
| Q2 2021 | $10,191,000 | -35.3% | 63,091 | -31.4% | 0.14% | -41.8% |
| Q1 2021 | $15,756,000 | -30.2% | 91,981 | -10.5% | 0.23% | -36.4% |
| Q4 2020 | $22,583,000 | +25.6% | 102,817 | -5.0% | 0.36% | -1.1% |
| Q3 2020 | $17,978,000 | +52.7% | 108,266 | +5.0% | 0.37% | +29.0% |
| Q2 2020 | $11,772,000 | +50.5% | 103,108 | +1.3% | 0.29% | +9.6% |
| Q1 2020 | $7,822,000 | -42.4% | 101,755 | -3.4% | 0.26% | -27.7% |
| Q4 2019 | $13,570,000 | -9.3% | 105,305 | -45.2% | 0.36% | -25.9% |
| Q3 2019 | $14,960,000 | -47.6% | 192,017 | -30.8% | 0.49% | -45.6% |
| Q2 2019 | $28,572,000 | +101.2% | 277,396 | +43.2% | 0.90% | +67.9% |
| Q1 2019 | $14,202,000 | +46.3% | 193,751 | -15.3% | 0.53% | +28.4% |
| Q4 2018 | $9,705,000 | -47.2% | 228,775 | -41.3% | 0.42% | -26.5% |
| Q3 2018 | $18,368,000 | -15.6% | 389,977 | -11.7% | 0.56% | -23.2% |
| Q2 2018 | $21,764,000 | +712.4% | 441,470 | +252.7% | 0.74% | +746.0% |
| Q1 2016 | $2,679,000 | -52.0% | 125,178 | -29.1% | 0.09% | -53.7% |
| Q4 2015 | $5,577,000 | +7.4% | 176,473 | +17.0% | 0.19% | +0.5% |
| Q3 2015 | $5,191,000 | +26.8% | 150,812 | +16.0% | 0.19% | +31.7% |
| Q2 2015 | $4,093,000 | +51.8% | 130,046 | +41.4% | 0.14% | +52.7% |
| Q1 2015 | $2,696,000 | +57.5% | 91,942 | -0.5% | 0.09% | +34.8% |
| Q4 2014 | $1,712,000 | +8.4% | 92,432 | +2.5% | 0.07% | +15.0% |
| Q3 2014 | $1,579,000 | -51.8% | 90,188 | -44.9% | 0.06% | -43.4% |
| Q2 2014 | $3,274,000 | -27.9% | 163,675 | -31.2% | 0.11% | -25.9% |
| Q1 2014 | $4,539,000 | – | 238,030 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |